Public and professional awareness: The Australian Medical Association, collaborating with professional bodies (such as RACGP and RACP), could develop targeted campaigns explaining regulatory approval processes and unregulated product risks, delivered through social media platforms where promotion occurs
Bu H, Li L, Li X, Guo J
When its released, the treatment will be the first of its kind on the market, making it a promising alternative to available medications
Weight regain after stopping GLP-1 class drugs is well-documented, and sudden cessation at high doses can cause a sharp return of appetite and rapid weight rebound
Oral semaglutide 14 mg provides roughly similar effects to injectable semaglutide 0.5 to 1 mg
Igor Wanko Mboumi, MD, FACS, a bariatric and general surgeon at Franciscan Physician Network Indy Southside Surgical in Indianapolis, explains how bariatric surgery and GLP-1 medications can promote weight loss